Denali Therapeutics IncNASDAQ:DNLI
- LAST PRICE29.4300
- TODAY'S CHANGE (%)0.1600 (0.5466%)
- Bid / Lots29.0000/ 9
- Ask / Lots29.9900/ 2
- Open / Previous Close29.5000 / 29.2700
- Day Range
- 52 Week Range
- Volume389,778
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DNLI |
|---|---|---|
| 09:32 ET | 5547 | 29.33 |
| 09:34 ET | 864 | 29.395 |
| 09:41 ET | 200 | 29.405 |
| 09:43 ET | 2297 | 29.39 |
| 09:45 ET | 400 | 29.35 |
| 09:48 ET | 100 | 29.37 |
| 09:50 ET | 100 | 29.36 |
| 09:54 ET | 1335 | 29.22 |
| 09:56 ET | 1255 | 29.345 |
| 09:57 ET | 954 | 29.32 |
| 09:59 ET | 100 | 29.36 |
| 10:01 ET | 2718 | 29.51 |
| 10:03 ET | 659 | 29.42 |
| 10:06 ET | 300 | 29.42 |
| 10:08 ET | 500 | 29.31 |
| 10:10 ET | 236 | 29.33 |
| 10:12 ET | 1577 | 29.42 |
| 10:14 ET | 100 | 29.39 |
| 10:15 ET | 103 | 29.39 |
| 10:17 ET | 400 | 29.39 |
| 10:19 ET | 200 | 29.32 |
| 10:21 ET | 300 | 29.38 |
| 10:24 ET | 200 | 29.42 |
| 10:26 ET | 100 | 29.43 |
| 10:28 ET | 300 | 29.46 |
| 10:30 ET | 300 | 29.47 |
| 10:32 ET | 3640 | 29.46 |
| 10:33 ET | 200 | 29.44 |
| 10:37 ET | 1000 | 29.505 |
| 10:39 ET | 1917 | 29.48 |
| 10:42 ET | 200 | 29.51 |
| 10:44 ET | 2200 | 29.51 |
| 10:46 ET | 400 | 29.52 |
| 10:48 ET | 1100 | 29.52 |
| 10:50 ET | 409 | 29.57 |
| 10:51 ET | 784 | 29.5 |
| 10:53 ET | 300 | 29.51 |
| 10:55 ET | 100 | 29.52 |
| 10:57 ET | 200 | 29.43 |
| 11:00 ET | 300 | 29.49 |
| 11:02 ET | 1200 | 29.575 |
| 11:08 ET | 1238 | 29.5867 |
| 11:09 ET | 200 | 29.6 |
| 11:11 ET | 300 | 29.57 |
| 11:13 ET | 300 | 29.57 |
| 11:15 ET | 100 | 29.57 |
| 11:18 ET | 600 | 29.59 |
| 11:20 ET | 200 | 29.62 |
| 11:22 ET | 449 | 29.56 |
| 11:24 ET | 600 | 29.575 |
| 11:26 ET | 100 | 29.57 |
| 11:27 ET | 200 | 29.51 |
| 11:29 ET | 1501 | 29.53 |
| 11:31 ET | 400 | 29.53 |
| 11:33 ET | 1000 | 29.59 |
| 11:36 ET | 1500 | 29.565 |
| 11:38 ET | 400 | 29.54 |
| 11:40 ET | 200 | 29.5 |
| 11:42 ET | 100 | 29.49 |
| 11:44 ET | 900 | 29.55 |
| 11:45 ET | 1250 | 29.54 |
| 11:47 ET | 1100 | 29.55 |
| 11:49 ET | 302 | 29.58 |
| 11:51 ET | 779 | 29.53 |
| 11:54 ET | 100 | 29.525 |
| 11:56 ET | 400 | 29.54 |
| 11:58 ET | 100 | 29.56 |
| 12:02 ET | 501 | 29.525 |
| 12:03 ET | 600 | 29.55 |
| 12:05 ET | 934 | 29.53 |
| 12:07 ET | 488 | 29.515 |
| 12:12 ET | 100 | 29.52 |
| 12:14 ET | 200 | 29.49 |
| 12:16 ET | 200 | 29.43 |
| 12:20 ET | 100 | 29.45 |
| 12:21 ET | 258 | 29.4499 |
| 12:23 ET | 200 | 29.43 |
| 12:30 ET | 412 | 29.43 |
| 12:32 ET | 2227 | 29.425 |
| 12:34 ET | 700 | 29.435 |
| 12:36 ET | 600 | 29.43 |
| 12:38 ET | 200 | 29.46 |
| 12:39 ET | 1991 | 29.505 |
| 12:43 ET | 700 | 29.485 |
| 12:45 ET | 200 | 29.465 |
| 12:48 ET | 200 | 29.49 |
| 12:52 ET | 731 | 29.49 |
| 12:54 ET | 1400 | 29.505 |
| 12:56 ET | 800 | 29.52 |
| 12:57 ET | 300 | 29.52 |
| 12:59 ET | 600 | 29.5084 |
| 01:01 ET | 250 | 29.515 |
| 01:03 ET | 914 | 29.55 |
| 01:06 ET | 295 | 29.58 |
| 01:08 ET | 300 | 29.575 |
| 01:10 ET | 1180 | 29.52 |
| 01:12 ET | 1200 | 29.525 |
| 01:14 ET | 200 | 29.52 |
| 01:15 ET | 300 | 29.535 |
| 01:17 ET | 1369 | 29.6 |
| 01:19 ET | 159 | 29.62 |
| 01:21 ET | 200 | 29.64 |
| 01:24 ET | 250 | 29.615 |
| 01:26 ET | 1280 | 29.713602 |
| 01:30 ET | 200 | 29.74 |
| 01:32 ET | 700 | 29.775 |
| 01:33 ET | 1341 | 29.75 |
| 01:35 ET | 405 | 29.735 |
| 01:37 ET | 300 | 29.72 |
| 01:39 ET | 800 | 29.66 |
| 01:42 ET | 500 | 29.655 |
| 01:44 ET | 100 | 29.66 |
| 01:46 ET | 300 | 29.65 |
| 01:48 ET | 3832 | 29.73 |
| 01:50 ET | 400 | 29.74 |
| 01:51 ET | 400 | 29.7 |
| 01:53 ET | 100 | 29.735 |
| 01:55 ET | 6663 | 29.765 |
| 01:57 ET | 400 | 29.7555 |
| 02:00 ET | 1770 | 29.76 |
| 02:02 ET | 400 | 29.76 |
| 02:04 ET | 500 | 29.74 |
| 02:06 ET | 450 | 29.74 |
| 02:08 ET | 377 | 29.73 |
| 02:09 ET | 600 | 29.73 |
| 02:11 ET | 300 | 29.74 |
| 02:13 ET | 1200 | 29.79 |
| 02:15 ET | 700 | 29.78 |
| 02:18 ET | 300 | 29.7646 |
| 02:20 ET | 1500 | 29.685 |
| 02:26 ET | 800 | 29.58 |
| 02:27 ET | 200 | 29.55 |
| 02:29 ET | 200 | 29.525 |
| 02:31 ET | 600 | 29.47 |
| 02:33 ET | 1600 | 29.5 |
| 02:36 ET | 701 | 29.49 |
| 02:38 ET | 500 | 29.48 |
| 02:40 ET | 2395 | 29.505 |
| 02:42 ET | 1700 | 29.55 |
| 02:44 ET | 200 | 29.545 |
| 02:45 ET | 300 | 29.57 |
| 02:47 ET | 200 | 29.61 |
| 02:49 ET | 200 | 29.62 |
| 02:51 ET | 2100 | 29.635 |
| 02:54 ET | 700 | 29.615 |
| 02:56 ET | 200 | 29.58 |
| 02:58 ET | 326 | 29.6 |
| 03:00 ET | 500 | 29.63 |
| 03:02 ET | 646 | 29.615 |
| 03:03 ET | 200 | 29.57 |
| 03:05 ET | 100 | 29.58 |
| 03:09 ET | 1100 | 29.58 |
| 03:12 ET | 684 | 29.51 |
| 03:14 ET | 1048 | 29.5 |
| 03:16 ET | 900 | 29.51 |
| 03:18 ET | 599 | 29.455 |
| 03:20 ET | 650 | 29.39 |
| 03:21 ET | 100 | 29.39 |
| 03:23 ET | 700 | 29.41 |
| 03:25 ET | 611 | 29.4 |
| 03:30 ET | 300 | 29.42 |
| 03:32 ET | 2092 | 29.45 |
| 03:34 ET | 1600 | 29.42 |
| 03:36 ET | 791 | 29.385 |
| 03:38 ET | 600 | 29.39 |
| 03:39 ET | 214 | 29.38 |
| 03:41 ET | 1100 | 29.38 |
| 03:43 ET | 1549 | 29.34 |
| 03:45 ET | 600 | 29.36 |
| 03:48 ET | 1737 | 29.39 |
| 03:50 ET | 800 | 29.4 |
| 03:52 ET | 2877 | 29.39 |
| 03:54 ET | 2396 | 29.4 |
| 03:56 ET | 4650 | 29.39 |
| 03:57 ET | 4384 | 29.475 |
| 03:59 ET | 96257 | 29.43 |
Sep 9, 2024
DJ Denali Therapeutics Price Target Maintained With a $35.00/Share by Cantor Fitzgerald, from 11:46AM ET on Monday Sep 09, 2024 by Dow Jones
11:46AM ET on Monday Sep 09, 2024 by Dow Jones
Sep 4, 2024
DJ Denali Therapeutics Price Target Maintained With a $90.00/Share by HC Wainwright & Co., from 7:47AM ET on Wednesday Sep 04, 2024 by Dow Jones
7:47AM ET on Wednesday Sep 04, 2024 by Dow JonesDJ Denali Therapeutics Is Maintained at Buy by B of A Securities, from 7:47AM ET on Wednesday Sep 04, 2024 by Dow Jones
7:47AM ET on Wednesday Sep 04, 2024 by Dow Jones
Sep 3, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Denali Therapeutics Inc | 4.2B | -10.3x | --- |
CRISPR Therapeutics AG | 4.0B | -14.8x | --- |
Axsome Therapeutics Inc | 4.3B | -13.8x | --- |
ADMA Biologics Inc | 4.5B | 138.0x | --- |
Apellis Pharmaceuticals Inc | 3.6B | -10.8x | --- |
TG Therapeutics Inc | 3.6B | 39.7x | --- |
Company Information
Denali Therapeutics Inc. is a biopharmaceutical company. The Company is focused on developing a portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases and lysosomal storage disease. The Company has a portfolio of both small molecule and biotherapeutic medicines, comprising seven product candidates in clinical development across seven indications as well as preclinical therapeutic candidates. Its three late-stage development programs include tividenofusp alfa (DNL310) for mucopolysaccharidosis II (MPS II); BIIB122/DNL151 (LRRK2 inhibitor) for Parkinson’s disease; and DNL343 (eIF2B activator) for amyotrophic lateral sclerosis (ALS). SAR443820/DNL788 (RIPK1 inhibitor) is being evaluated in a Phase II study for multiple sclerosis (MS). In addition, it has a Phase I/II study of TAK-594/DNL593 for frontotemporal dementia-granulin (FTD-GRN) and a Phase I/II study of DNL126 for MPS IIIA (Sanfilippo syndrome).
Contact Information
- Headquarters
- 161 Oyster Point BlvdSOUTH SAN FRANCISCO, CA, United States 94080-1910
- Phone
- 650-866-8548
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Vicki Sato
- President, Chief Executive Officer, Director
- Ryan Watts
- Chief Financial Officer, Chief Operating Officer, Company Secretary
- Alexander Schuth
- Chief Medical Officer
- Carole Ho
- Director
- Steven Krognes
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.2B |
|---|---|
Revenue (TTM) | $1.3M |
Shares Outstanding | 143.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.37 |
EPS | $-2.85 |
Book Value | $7.45 |
P/E Ratio | -10.3x |
Price/Sales (TTM) | 3,307.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -37,938.04% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
